- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Multiple Myeloma in United Kingdom
Total 6636 results
-
National Cancer Institute (NCI)RecruitingPlasmacytoma | Refractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Margarida Magalhaes-SilvermanNational Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Primary Systemic Amyloidosis | Light Chain Deposition Disease | Extramedullary Plasmacytoma | Isolated Plasmacytoma of BoneUnited States
-
University of LeedsMerck Sharp & Dohme LLC; Myeloma UKCompletedMultiple MyelomaUnited Kingdom
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)TerminatedLeukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.CompletedMultiple Myeloma | High Risk Smoldering Multiple MyelomaUnited States
-
Hoffmann-La RocheCompletedMultiple Myeloma, NeoplasmsUnited States, China, France, Spain, United Kingdom, Germany
-
Memorial Sloan Kettering Cancer CenterRecruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapse Multiple MyelomaUnited States
-
Case Comprehensive Cancer CenterWithdrawnMyeloma | Smoldering Myeloma | Monoclonal GammopathyUnited States
-
National Cancer Institute (NCI)TerminatedMonoclonal Gammopathy of Undetermined Significance | Smoldering MyelomaUnited States
-
Cartesian TherapeuticsCompleted
-
AbbVieRecruitingRelapsed/Refractory Multiple MyelomaUnited States, Australia, Israel, United Kingdom
-
The Christie NHS Foundation TrustCellCentric Ltd.Not yet recruitingMultiple MyelomaUnited Kingdom
-
Cristiana Costa Chase, DONot yet recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingSmoldering Plasma Cell MyelomaUnited States
-
Roswell Park Cancer InstituteCelgeneActive, not recruitingPlasma Cell Myeloma | Partial Response of Multiple Myeloma or Plasma Cell LeukemiaUnited States
-
Prof Jamie CavenaghNovartis; Myeloma UKUnknownMultiple MyelomaUnited Kingdom
-
Royal Marsden NHS Foundation TrustCompleted
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustRecruitingMultiple MyelomaUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterExelixisCompletedRelapsed or Refractory Multiple MyelomaUnited States
-
Royal National Orthopaedic Hospital NHS TrustTerminatedMultiple MyelomaUnited Kingdom
-
Gilead SciencesCompletedChronic Lymphocytic Leukemia (CLL) | Acute Myeloid Leukemia (AML) | Multiple Myeloma (MM) | Lymphoma, Non-Hodgkin (NHL)United States
-
University of LiverpoolGenzyme, a Sanofi CompanyUnknownLymphoma | Lymphoproliferative Disorders | Multiple Myeloma | Plasma Cell DyscrasiaUnited Kingdom
-
SanofiActive, not recruitingPlasma Cell MyelomaItaly, Korea, Republic of, Norway, Canada, Spain, Germany, Greece, Lithuania, Sweden, Israel, Hungary, France, Japan, Australia, China, Denmark, Czechia, Turkey, United States, Brazil, Ireland, New Zealand, Poland, United Kingdom
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Celgene; The Leukemia and Lymphoma Society; Multiple Myeloma... and other collaboratorsCompletedSmoldering Multiple Myeloma | Smoldering MyelomaUnited States
-
OncotherapeuticsWithdrawnStage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Plasma Cell NeoplasmUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
National Cancer Institute (NCI)TerminatedMultiple Myeloma | Smoldering Multiple Myeloma | MyelomaUnited States
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of CopenhagenActive, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMonoclonal Gammopathy of Undetermined Significance | Smoldering Plasma Cell MyelomaUnited States
-
The Royal Wolverhampton Hospitals NHS TrustUniversity of WolverhamptonRecruiting
-
Imperial College LondonGlaxoSmithKline; University College, London; Medical Research Council; Queen Mary... and other collaboratorsCompletedRelapsing-remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
K36 Therapeutics, Inc.RecruitingMultiple Myeloma | Myeloma | Myeloma MultipleUnited States, France, Spain, Canada
-
University of UtahRecruitingSmoldering Multiple MyelomaUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedMultiple Myeloma and Plasma Cell Neoplasm | Precancerous ConditionUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedLeukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Multiple Myeloma Research ConsortiumEli Lilly and Company; GlaxoSmithKline; AbbVie; Takeda; Genentech, Inc.; Celgene Corporation and other collaboratorsRecruitingRelapsed Refractory Multiple MyelomaUnited States
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaGermany, Korea, Republic of, Italy, France, Japan, Israel, Belgium, Denmark, Sweden, China, Spain, Czechia, Poland, Australia, Netherlands, Argentina, Canada, United Kingdom, Greece, Brazil, India
-
CASI Pharmaceuticals, Inc.Active, not recruitingMultiple MyelomaUnited Kingdom, France
-
PerspectumRecruiting
-
M.D. Anderson Cancer CenterRecruiting
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisUnited Kingdom
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisUnited Kingdom
-
Janssen Pharmaceutica N.V., BelgiumRecruitingRelapsed/Refractory Multiple MyelomaGermany, Italy, Belgium, Spain, Netherlands, France, United Kingdom
-
Abramson Cancer Center at Penn MedicineRecruiting
-
Autolus LimitedTerminatedMultiple MyelomaUnited Kingdom, Netherlands
-
Sirtris, a GSK CompanyGlaxoSmithKlineTerminatedMultiple MyelomaUnited Kingdom, Denmark
-
Queen Mary University of LondonTakeda Pharmaceuticals International, Inc.RecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
University of GlasgowNHS Ayrshire and Arran; AKMCompletedMultiple Sclerosis, ProgressiveUnited Kingdom
-
University of ArkansasCompletedMULTIPLE MYELOMAUnited States
-
AstraZenecaCompletedAcute Myeloid LeukaemiaUnited Kingdom